American Society of Hematology

SHERPA: Blue

People

  1. Scheinberg
    Scheinberg
  2. Berman
    Berman
  3. Bernal
    Bernal
  4. Dao
    Dao
  5. Park
    Park
  6. Sadelain
    Sadelain
  7. Stefanski
    Stefanski
  8. Wang
    Wang
  9. Carrasquillo
    Carrasquillo
  10. Kelly
    Kelly

Groups

  1. Adult Leukemia (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Hematologic Malignancies, Division of (17)
  5. GSK Faculty (16)
  6. Hematologic Malignancies Research (15)
  7. Sloan Kettering Institute Faculty (12)
  8. Molecular Pharmacology and Chemistry Program Faculty (10)
  9. Tow Center for Developmental Oncology (TCDO) (9)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
Search Within
  1. "Mark Frattini"
  2. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (3)
Groups
  1. Adult Leukemia (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Hematologic Malignancies, Division of (17)
  5. GSK Faculty (16)
  6. Hematologic Malignancies Research (15)

More Groups

People
  1. Mark Frattini (17)
  2. Joseph Jurcic (15)
  3. Peter Maslak (11)
  4. Renier Brentjens (11)
  5. Mark Heaney (10)
  6. David Scheinberg (8)

More People

Years
  1. 2018 (1)
  2. 2012 (5)
  3. 2011 (3)
  4. 2010 (4)
  5. 2009 (2)
  6. 2008 (1)

More Years

Publications
  1. Blood (16)
  2. Blood Advances (1)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • High dose cytarabine and mitoxantrone in combination with dasatinib as active induction therapy in adult patients with Philadelphia chromosome positive (ph plus ) acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Lamanna, N.; Weiss, M.; Berman, E.; Frattini, M. G.; Heaney, M.; Jurcic, J. G.; Rosenblat, T. L.; Landau, H.; Weissbrot, H.; Maslak, P. G.
    Blood (2012)

    Fulltext@MSK | Save
  • Micafungin versus posaconazole anti-fungal prophylaxis in adult patients with acute leukemia undergoing induction chemotherapy
    Meeting Abstract

    Halton, E.; Chung, D.; Xiao, K.; Quintanilla, H.; Baldwin, C.; Baird, P.; Berman, E.; Brentjens, R. J.; Heaney, M.; Jurcic, J. G.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Molecular remission and B cell aplasia induced in a first cohort of adults with relapsed B-ALL treated with 19-28z CAR-targeted T cells
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X. Y.; Park, J. H.; Stefanski, J.; Taylor, C.; He, Q.; Olszewska, M.; Wasielewska, T.; Borquez-Ojeda, O.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Characteristic proinflammatory serum cytokine profiles in patients with B-Cell chronic lymphocytic leukemia
    Meeting Abstract

    Harding, J. J.; Yeh, R.; Nikhamin, Y.; Frattini, M.; Lamanna, N.; Jurcic, J. G.; Heaney, M.; Brentjens, R.
    Blood (2010)

    Fulltext@MSK | Save